Covalon Receives FDA Approval for Antimicrobial Silicone Adhesive Film
Covalon Technologies has announced it has received FDA approval for its IV Clear film dressing, according to a news release.
IV Clear is an antimicrobial silicone adhesive film dressing designed for securing vascular intravenous access devices.
"IV Clear is truly a new innovation in the fight against catheter-related blood stream infections, for which CDC calls one of the most deadly and costly threats to patient safety," said Brian Pedlar, Covalon's CEO, in the release. "Having an antimicrobial silicone adhesive is a clear advantage over the older generation of patches, pads or acrylic adhesive technologies currently available in the market. With over 350 million IV catheter stabilization devices used in the United States alone and the adoption of antimicrobial securement devices experiencing double-digit growth, we fully expect IV Clear to be a strong competitor in the market."
IV Clear is designed to cover and protect insertion sites and to secure intravenous devices to a patient's skin.
FDA approval included the following indications for use: IV catheters, central venous lines, peripherally inserted central catheters, suction catheters, epidural catheters, hemodialysis catheters, orthopedic pins, other intravascular catheters and percutaneous devices.
Covalon is headquartered in Mississauga, Ontario, Canada.
Related Articles on FDA Approvals:
© Copyright ASC COMMUNICATIONS 2012. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.
- Senate Introduces Companion Medicare RAC Reform Bill
- Drs. Brian Cole, Anthony Romeo of Midwest Orthopaedics at Rush Among Top Orthopedic Surgeons Contributing to Orthopedic Literature
- Spinal Elements Upgrades to 40,000-Square-Foot Headquarters
- UnitedHealth, Aetna, Cigna to Sit Out of California's Health Insurance Exchange
- Rhode Island Nixes "Confidential" Prices Between Payors, Providers